Project Grant K24AR087610
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $170,316 to the University of California, Davis on August 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to support a four-year research career development initiative focused on trauma-induced heterotopic ossification (THO). The project, concluding July 31, 2029, delivers research services aimed at understanding and mitigating...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $169,560 Project Grant to The Regents of the University of California, San Francisco (UCSF) effective July 1, 2025, through May 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This mentored career development award funds comprehensive research to elucidate the role of endogenous opioid peptides—specifically enkephalin and...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Yale University a $170,931 Project Grant effective August 1, 2025, through June 30, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This five-year award supports an integrated research and career development program for Dr. Diana Athonvarangkul, a physician-scientist, to achieve independence as an investigator in bone and mineral...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $175,373 to The Hospital for Special Surgery Fund, Inc. on July 1, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This K23 career development award supports Dr. Medha Barbhaiya's research focused on assessing risk for poor outcomes in antiphospholipid syndrome (APS). The project will deliver three primary products: (1)...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Pennsylvania $390,095.29 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) for the project "Hydrogel Therapies for Alopecia Areata." The award, obligated on May 1, 2025, with completion targeted for July 31, 2025, supports a K08 career development award to Dr. Leo Wang. The project delivers integrated...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $151,040 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded April 15, 2026, with completion targeted for November 30, 2028. This project supports the development of muscle-optimized non-viral gene editors designed to improve gene editing efficiency for Duchenne...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a K01 Mentored Research Scientist Development Award totaling $122,563 to Boston Children's Hospital, with an award date of August 18, 2025, and completion date of July 31, 2030. This award supports advanced research training and protected time for Dr. Taehyeung Kim to develop as an independent investigator specializing in functional genomics and the regulatory...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $224,100 in project grant funding to the Regents of the University of California at Riverside on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This three-year project, concluding August 31, 2028, will deliver research investigating epigenetic factors that control epidermal stem cell longevity in adult skin....
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $249,000 Project Grant to the University of California, Irvine, effective February 1, 2026 through January 31, 2029, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award supports basic science research investigating the repair and immunomodulatory functions of lymphatic vessels during wound healing. The research will...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $400,693 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, through August 31, 2027. This research project investigates the role of PIEZO2-mediated mechanosensory signaling in pediatric clubfoot deformity recurrence following surgical...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a K24 Mentoring Career Development Award totaling $123,108 to The University of Texas Southwestern Medical Center, effective April 8, 2026, through March 31, 2031. This project grant supports Dr. Tamia Harris-Tryon's scientific career development and mentoring activities in translational research focused on inflammatory skin diseases. The award funds professional development through coursework and training, execution of novel research projects, and mentoring of trainees and faculty. Dr. Harris-Tryon's research program applies translational patient-oriented research approaches to investigate how androgen antagonism can be leveraged as a therapeutic strategy for treating inflammatory skin conditions, building upon her established basic science findings demonstrating immune system regulation of androgen production in skin cells. The grant supports the expansion of Dr. Harris-Tryon's independent research program at UT Southwestern's Department of Dermatology in Dallas, Texas, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The K24 award recognizes her dual expertise as both an active clinical dermatologist and basic science researcher, enabling her to advance translational dermatological research while developing the next generation of scientists in this field. This career development award builds upon her prior NIH funding history, including previous K08 and R01 awards, positioning her research program to generate novel therapeutic approaches for dermatological conditions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $123.1k | 4/9/26 |